Gaurav Kharya/LinkedIn
Jun 24, 2026, 16:49
Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
Gaurav Kharya, Director, Dept. of Bone Marrow Transplant and Cellular Therapy at Indraprastha Apollo Hospitals, shared a post on LinkedIn:
“Some issues cannot wait.
Access to safe blood for people who depend on regular transfusions is one of them-because delays can have life-threatening consequences.
My article in The Week looks at why ensuring timely and safe blood access remains critical, and why sustained attention and action are needed for those who rely on it every day.
Indraprastha Apollo Hospitals, New Delhi Cellogen Therapeutics
Bridging the gaps: Safe blood, lifesaving care, and a cure for sickle cell disease – The Week.”
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 18:43Hugh Nguyen: Honored to Accept the Friend of Singapore Red Cross Award
-
Sep 24, 2026, 18:42Titilope Fasipe: Proud to Support American Society of Hematology’s SCD Initiative
-
Sep 24, 2026, 18:34Ifeanyichukwu Ifechidere: Why Coagulation Samples Can Be “Too Valuable to Throw Away”?
-
Sep 24, 2026, 18:33Aswin K. Mohan: When a Superpower Hears the Call for Blood
-
Sep 24, 2026, 18:31Mercy Lung’aho: Anemia Is Not Only An Iron Problem
-
Sep 24, 2026, 18:29Nick Hanson: Before a Dementia Diagnosis Check Vitamin B12
-
Sep 24, 2026, 18:28Rachel McBryan: Nearly One in Five Older Canadians Has Low Vitamin B12
-
Sep 24, 2026, 18:27Kemal Karaagac: Early DOAC Initiation After Acute Ischaemic Stroke in Atrial Fibrillation
-
Sep 24, 2026, 18:26Mohammed A. AlOmar: What Characterizes Young Stroke in the UAE?